Trimethaphan versus sodium nitroprusside for the control of proximal hypertension during thoracic aortic cross-clamping

The effects on spinal cord ischemia

Joseph I. Simpson, Thomas R. Eide, Sheldon B. Newman, Gerald A. Schiff, David Levine, Rodney Bermudez, Thomas D'Ambra, Philip W. Lebowitz

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Sodium nitroprusside (SNP) has been used to control the proximal hypertension associated with thoracic aortic cross-clamping (TACC) during thoracic aortic surgery. It worsens neurologic outcome, presumably by further decreasing distal arterial pressure and increasing cerebrospinal fluid (CSF) pressure, thereby worsening the spinal cord perfusion pressure (SCPP). Trimethaphan does not increase CSF pressure. Therefore, the present study investigates the effect of trimethaphan versus SNP to control proximal hypertension during TACC on neurologic outcome. Two groups, each with eight mongrel dogs, were studied. All animals underwent descending TACC for 45 min. The mean proximal aortic blood pressure was main rained at 95-100 mm Hg by the use of SNP or trimethaphan. Distal aortic pressure was allowed to vary. The dogs were neurologically evaluated 24 and 48 h later by a blinded observer. During cross-clamping, there was no difference in mean proximal aortic pressure between groups. After 10 min of cross-clamping, distal aortic pressure was higher (P < 0.01), CSF pressure was lower (P < 0.01), and SCPP was higher (P < 0.005) in the trimethaphan group as compared with the SNP group (group effect). Neurologic outcome as assessed by Tarlov's score was better at 24 and 48 h in the trimethaphan group (P < 0.05). Histopathologic injury trended with worsened neurologic outcome. We conclude that 1) trimethaphan produced higher SCPP than SNP, and 2) neurologic outcome was better in the trimethaphan group.

Original languageEnglish (US)
Pages (from-to)68-74
Number of pages7
JournalAnesthesia and Analgesia
Volume82
Issue number1
DOIs
StatePublished - 1996

Fingerprint

Trimethaphan
Spinal Cord Ischemia
Nitroprusside
Constriction
Thorax
Hypertension
Nervous System
Arterial Pressure
Cerebrospinal Fluid Pressure
Spinal Cord
Perfusion
Pressure
Dogs
Thoracic Surgery
Wounds and Injuries

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Trimethaphan versus sodium nitroprusside for the control of proximal hypertension during thoracic aortic cross-clamping : The effects on spinal cord ischemia. / Simpson, Joseph I.; Eide, Thomas R.; Newman, Sheldon B.; Schiff, Gerald A.; Levine, David; Bermudez, Rodney; D'Ambra, Thomas; Lebowitz, Philip W.

In: Anesthesia and Analgesia, Vol. 82, No. 1, 1996, p. 68-74.

Research output: Contribution to journalArticle

Simpson, Joseph I. ; Eide, Thomas R. ; Newman, Sheldon B. ; Schiff, Gerald A. ; Levine, David ; Bermudez, Rodney ; D'Ambra, Thomas ; Lebowitz, Philip W. / Trimethaphan versus sodium nitroprusside for the control of proximal hypertension during thoracic aortic cross-clamping : The effects on spinal cord ischemia. In: Anesthesia and Analgesia. 1996 ; Vol. 82, No. 1. pp. 68-74.
@article{462bcde757934525b10c69ab44a13764,
title = "Trimethaphan versus sodium nitroprusside for the control of proximal hypertension during thoracic aortic cross-clamping: The effects on spinal cord ischemia",
abstract = "Sodium nitroprusside (SNP) has been used to control the proximal hypertension associated with thoracic aortic cross-clamping (TACC) during thoracic aortic surgery. It worsens neurologic outcome, presumably by further decreasing distal arterial pressure and increasing cerebrospinal fluid (CSF) pressure, thereby worsening the spinal cord perfusion pressure (SCPP). Trimethaphan does not increase CSF pressure. Therefore, the present study investigates the effect of trimethaphan versus SNP to control proximal hypertension during TACC on neurologic outcome. Two groups, each with eight mongrel dogs, were studied. All animals underwent descending TACC for 45 min. The mean proximal aortic blood pressure was main rained at 95-100 mm Hg by the use of SNP or trimethaphan. Distal aortic pressure was allowed to vary. The dogs were neurologically evaluated 24 and 48 h later by a blinded observer. During cross-clamping, there was no difference in mean proximal aortic pressure between groups. After 10 min of cross-clamping, distal aortic pressure was higher (P < 0.01), CSF pressure was lower (P < 0.01), and SCPP was higher (P < 0.005) in the trimethaphan group as compared with the SNP group (group effect). Neurologic outcome as assessed by Tarlov's score was better at 24 and 48 h in the trimethaphan group (P < 0.05). Histopathologic injury trended with worsened neurologic outcome. We conclude that 1) trimethaphan produced higher SCPP than SNP, and 2) neurologic outcome was better in the trimethaphan group.",
author = "Simpson, {Joseph I.} and Eide, {Thomas R.} and Newman, {Sheldon B.} and Schiff, {Gerald A.} and David Levine and Rodney Bermudez and Thomas D'Ambra and Lebowitz, {Philip W.}",
year = "1996",
doi = "10.1097/00000539-199601000-00012",
language = "English (US)",
volume = "82",
pages = "68--74",
journal = "Anesthesia and Analgesia",
issn = "0003-2999",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Trimethaphan versus sodium nitroprusside for the control of proximal hypertension during thoracic aortic cross-clamping

T2 - The effects on spinal cord ischemia

AU - Simpson, Joseph I.

AU - Eide, Thomas R.

AU - Newman, Sheldon B.

AU - Schiff, Gerald A.

AU - Levine, David

AU - Bermudez, Rodney

AU - D'Ambra, Thomas

AU - Lebowitz, Philip W.

PY - 1996

Y1 - 1996

N2 - Sodium nitroprusside (SNP) has been used to control the proximal hypertension associated with thoracic aortic cross-clamping (TACC) during thoracic aortic surgery. It worsens neurologic outcome, presumably by further decreasing distal arterial pressure and increasing cerebrospinal fluid (CSF) pressure, thereby worsening the spinal cord perfusion pressure (SCPP). Trimethaphan does not increase CSF pressure. Therefore, the present study investigates the effect of trimethaphan versus SNP to control proximal hypertension during TACC on neurologic outcome. Two groups, each with eight mongrel dogs, were studied. All animals underwent descending TACC for 45 min. The mean proximal aortic blood pressure was main rained at 95-100 mm Hg by the use of SNP or trimethaphan. Distal aortic pressure was allowed to vary. The dogs were neurologically evaluated 24 and 48 h later by a blinded observer. During cross-clamping, there was no difference in mean proximal aortic pressure between groups. After 10 min of cross-clamping, distal aortic pressure was higher (P < 0.01), CSF pressure was lower (P < 0.01), and SCPP was higher (P < 0.005) in the trimethaphan group as compared with the SNP group (group effect). Neurologic outcome as assessed by Tarlov's score was better at 24 and 48 h in the trimethaphan group (P < 0.05). Histopathologic injury trended with worsened neurologic outcome. We conclude that 1) trimethaphan produced higher SCPP than SNP, and 2) neurologic outcome was better in the trimethaphan group.

AB - Sodium nitroprusside (SNP) has been used to control the proximal hypertension associated with thoracic aortic cross-clamping (TACC) during thoracic aortic surgery. It worsens neurologic outcome, presumably by further decreasing distal arterial pressure and increasing cerebrospinal fluid (CSF) pressure, thereby worsening the spinal cord perfusion pressure (SCPP). Trimethaphan does not increase CSF pressure. Therefore, the present study investigates the effect of trimethaphan versus SNP to control proximal hypertension during TACC on neurologic outcome. Two groups, each with eight mongrel dogs, were studied. All animals underwent descending TACC for 45 min. The mean proximal aortic blood pressure was main rained at 95-100 mm Hg by the use of SNP or trimethaphan. Distal aortic pressure was allowed to vary. The dogs were neurologically evaluated 24 and 48 h later by a blinded observer. During cross-clamping, there was no difference in mean proximal aortic pressure between groups. After 10 min of cross-clamping, distal aortic pressure was higher (P < 0.01), CSF pressure was lower (P < 0.01), and SCPP was higher (P < 0.005) in the trimethaphan group as compared with the SNP group (group effect). Neurologic outcome as assessed by Tarlov's score was better at 24 and 48 h in the trimethaphan group (P < 0.05). Histopathologic injury trended with worsened neurologic outcome. We conclude that 1) trimethaphan produced higher SCPP than SNP, and 2) neurologic outcome was better in the trimethaphan group.

UR - http://www.scopus.com/inward/record.url?scp=0030068751&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030068751&partnerID=8YFLogxK

U2 - 10.1097/00000539-199601000-00012

DO - 10.1097/00000539-199601000-00012

M3 - Article

VL - 82

SP - 68

EP - 74

JO - Anesthesia and Analgesia

JF - Anesthesia and Analgesia

SN - 0003-2999

IS - 1

ER -